ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BMEA vs CNTB // REVENUE GROWTH (YOY)

Biomea Fusion Inc. (NASDAQ) VS. Connect Biopharma Holdings Limited (NASDAQ) • 15-METRIC TALLY: BMEA 0 — CNTB 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BMEA VS. CNTB) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BMEA CNTB SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) ACTIVE — -65.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 2/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 31.0 32.0 -1.00 CNTB /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $47.8M $48.9M -$1.1M CNTB /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BMEA REV CNTB REV BMEA GROSS % CNTB GROSS % BMEA FCF CNTB FCF
FY 2025 $233.8M $64.0K — — -$70.4M -$51.6M
FY 2024 $403.4M $26.0M — — -$120.3M -$24.4M
FY 2023 $353.2M $193.4M — — -$96.6M -$47.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BMEA // BETA —
CNTB // BETA —